premium content
EKF Diagnostics – argues remains positive of capacity expansion “significant benefit”... but not sufficiently for the CEO to remain in situ?!
EKF Diagnostics (EKF) has issued a “trading update” – it stating “reflecting strong growth in the core established business… also gives a progress update on the expansion of the Life Sciences enzyme fermentation business and on the transition of Contract Manufacturing & Laboratory Testing into non-COVID revenues”. So what of a share price response to currently 32.6p, approaching 17% lower?- By Steve Moore |
- 6 February 2023, 15:30 |
premium content
Tintra – was the loss in January 2022 accounts understated by almost £600,000?
Tintra (TNT) is, following exposes HERE and HERE, now drowning in more red flags than one might see on a May Day parade in Moscow. But it gets worse, far worse.- By Tom Winnifrith, the Sheriff of AIM |
- 6 February 2023, 14:19 |
premium content
Tom Winnifrith Bearcast: Manchester City should suffer a Saracens+ penalty and here is why
I start with Manchester City and then move onto Tintra (TNT) where i a am now working on a 3rd exposé in three days. It has all the hallmarks of a zero and regulators need to step in. In the same vein I discuss Caracal Gold (GCAT) amid a dash for trash. Then it is onto HUI (HUI) and Powerhouse (PHE) and finally I discuss Vast Resources (VAST) where - as I warned a placing dump followed the Zim diamond pump. This will not be the last bailout placing.- By Tom Winnifrith |
- 6 February 2023, 13:50 |
Engage XR – fundraise (discounted, natch) “to capitalise on the momentum of its ENGAGE platform”. Really?
Previously writing on Engage XR (EXR), two weeks ago with it describing itself as “a leading metaverse technology company”, I concluded to be particularly wary of announcements such as its latest “showcases first AI-powered virtual employee”. Now a “pleased to announce… placing”. Quelle surprise!
- By Steve Moore |
- 6 February 2023, 13:49 |
premium content
NEW BOMBSHELL EXPOSE: Tintra – what is going on with Tintra 3.0
Following my bombshell revelations around Tintra Acquisitions on Saturday which AIM Regulation has confirmed to me that it is now looking into, there is a new massive red flag to hoist. If anyone cannot see how Tintra (TNT) stinks and is uninvestable, they need to get a guide dog and a white stick pronto.- By Tom Winnifrith, the Sheriff of AIM |
- 6 February 2023, 11:40 |
ShareProphets readers tips for 2023 prize competition – first month update
Having asked for readers tips for 2023 for the prize of 1/2 litre of Tom Winnifrith's Greek Hovel olive oil (2023 harvest) HERE, the following is the first of the monthly updates (to be eligible needed to have selected, on a once per username basis, a buy & sell pick from the LSE, AIM casino or Aquis lobster pot and the stocks not to have been suspended at the commencement of 2023).
- By Steve Moore |
- 6 February 2023, 10:05 |
premium content
I have no desire to buy either stock, but don’t worry about new shares at 3i Infrastructure or more buybacks at Shell
At the end of September last year, about the time when a 4,000-word comedy essay writer in yesterday’s Sunday press was the country’s PM, I wrote that for any investors who were too scared to invest in most shares, then “you can do a lot worse than 3i Infrastructure (3IN)” HERE. These shares, like a bunch of other FTSE 350 names, are up since then but today I notice that its board “is pleased to announce a proposed placing of ordinary shares in the capital of the Company conducted under the existing non-pre-emptive authorities granted by shareholders at the Company's annual general meeting”. How exciting (not). And what about all those share buybacks that have been happening elsewhere in FTSE 350 names?
- By Chris Bailey |
- 6 February 2023, 09:46 |
premium content
TruSpine – Was It Telling Porky Pies In January RNS?
I’m not sure that one can believe anything that Aquis lobster-potted TruSpine (TSP) says. Its IPO didn’t raise the funds stated, it failed to meet the year-end deadline following IPO to submit its FDA approval application for its CerviLok spinal support system and has missed just about every deadline set. On 3rd January 2023, having run perilously short of funds, it told us that it had entered into a Bridge Loan facility – £200,000 to be available immediately.- By Nigel Somerville |
- 6 February 2023, 09:04 |
premium content
Zamaz – was anything in the September 2 FCA approved prospectus actually real ? Financing terminated!
Why on earth did the FCA approve the Standard List prospectus of Zamaz (ZAMZ), the new dog created by Dominic White of the fraud Supply@ME Capital (SYME) infamy. The £77 million valuation was a joke as I explained HERE. But more importantly, we can now say that almost nothing in that document was real.- By Tom Winnifrith |
- 6 February 2023, 08:38 |
The View From The Montana Log-Cabin As Gold Reverses (But For How Long?)
Gold has gone into reverse. So much for my “ouzo on ice” piece mid-week, in the wake of the Fed’s quarter-point rise in interest rates, distracted as I was by the Chinese spying on the Montana Log-Cabin. Mark Watson-Mitchell was indeed right: nothing moves in straight lines – Gold ended the week at $1864, sharply down on the $1928 of a week ago. So is the Gold bull all off, then? Certainly not!- By Nigel Somerville |
- 6 February 2023, 08:19 |
Doctor, Doctor Do You Need More Surgeries? Yes, and this Renter Belter Will Make Money by Supplying them
Hello share counters. A company I’ve commended to you before and for which my optimism is even stronger, if anything, is Primary Health Properties (PHP). It owns and rents out doctors’ surgeries to GP’s in Blighty and the Irish Republic. More than 520 of them, in fact. You’ll know, I fancy, that doctors are dealing with more and more patients these days and will need the best premises to treat them.- By Malcolm Stacey |
- 6 February 2023, 08:12 |
premium content
I'm not surprised to see Canadian Overseas in deep financial trouble after my warnings, but I don't think its game over
I’ve been warning for a while now that Canadian Overseas Petroleum (COPL) could find itself in financial trouble due to the large amount of debt that it is carrying.- By Gary Newman |
- 5 February 2023, 15:05 |
premium content
Tom Winnifrith Bearcast: feeling a bit fragile today for reasons you can guess & is there any way back for disgraced pot stocks?
I am sure you can guess the sport related reasons for the fragility. Blame my pal C who you may have met at ShareStock last year. It is all his fault. I start with that and a milestone this website reached on Friday. Then onto pot/CBD stocks including Seed Innovations (SEED), Chill Brands (CHLL), Oxford Cannabinoid (OCTP), Love Hemp (LIFE) and Cellular Goods (CBX) and "investment expert" Clem Chambers of ADVFN (AFN) infamy. No sniggering at the back please- By Tom Winnifrith |
- 5 February 2023, 15:01 |
Wynnstay – “exceptional” full-year results, further ahead of expectations to come. BUY
Agricultural supplies group Wynnstay (WYN) has announced what it emphasises are “exceptional” results for its year ended 31st October 2022 and that, though there are now some headwinds, it is still “well-positioned”.- By Hotstockrockets |
- 5 February 2023, 12:47 |
Video: All Pistons are Firing for Gold to Reach New Highs this Year
Analyst and trader Michael Moor believes in technical analysis. Whatever.- By Tom Winnifrith |
- 5 February 2023, 12:43 |
premium content
UPGRADE: Kefi Gold and Copper – Q4 operational update, stance upgraded to STRONG BUY
Kefi Gold & Copper (KEFI) has issued a fourth quarter 2022 operational update, including re-emphasising on Tulu Kapi gold project financing that it “expects all outstanding issues to be addressed imminently”.- By Hotstockrockets |
- 5 February 2023, 11:52 |
premium content
Sunday Long Reads: 12 Hours in an NHS Ward, Oil Thieves of Nigeria, DJ and War Crimes, Wagner’s Prisoner Army, Fixing French Nuclear Plants
Here are five long reads that have nothing to do with shares. Put the kettle on, find a comfy chair. You have the time, don't you?
- By Darren Atwater |
- 5 February 2023, 10:52 |
Visual Aid: Tesla’s Unrivaled Profit Margins
From Visual Capitalist,this week’s graphic illustrates recent data compiled by Reuters showing that Tesla’s margins are significantly higher than those of its rivals, both in terms of gross and net profit. Our graphic illustrates the net figures in US dollars.- By Darren Atwater |
- 5 February 2023, 10:50 |
premium content
Gold: you're indestructible (even if the price goes down sometimes)
I read in the Sunday press that allegedly the “FCA offers to bend the rules to land Arm float”. That is certainly something to keep an eye on this year, especially as the FTSE 100 - unlike many of its global peers - is somewhat light in the excitable world of technology stocks. An area the FTSE 100 is heavily exposed to however is the commodity sector. Last week may have seen “London’s FTSE 100 Index ended the week on a high having reached its highest ever score, beating the previous record of 7,903.5 set in May 2018”, but you may have seen that natural gas, oil and silver prices have fallen even further this year and even my beloved gold is only up a couple of percent in dollar terms over the first five or so weeks of 2023…- By Chris Bailey of Financial Orbit |
- 5 February 2023, 10:48 |
premium content
Notes from Underground – Most read articles for the week ending 4 Feb 2023
The most-read non-Tom article this week is actually the Visual Capitalist graphic, The Biggest Global Risks of 2023, which is a first. The most-read non-Tom non graphic article is by Chris Bailey with Why FTSE 100 stocks such as GSK and Vodafone are always worth thinking about (but only one of them is a buy today) at No 3 or No 8 including Bearcasts.
- By Darren Atwater |
- 5 February 2023, 10:40 |